Cerevel Therapeutics Holdings, Inc.
NASDAQ:CERE
44.96 (USD) • At close July 31, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2015 | 2014 | 2013 | 2012 | 2001 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||||
| Net Income
| -432.842 | -351.511 | -225.334 | -152.142 | -128.389 | -28.156 | -29.321 | -32.511 | -29.41 | 0 |
| Depreciation & Amortization
| 5.627 | 4.903 | 2.731 | 0.397 | 0.177 | 0.657 | 1.517 | 1.912 | 2.059 | 0 |
| Deferred Income Tax
| -2.038 | 0 | 3.881 | 3.27 | 46.442 | 0 | 0 | 0 | -49.085 | 0 |
| Stock Based Compensation
| 69.41 | 38.78 | 23.941 | 10.521 | 8.311 | 2.265 | 3.068 | 3.31 | 1.909 | 0 |
| Change In Working Capital
| 16.113 | 28.064 | 15.541 | 17.707 | 0.343 | -20.063 | -3.832 | -22.787 | 49.085 | 0 |
| Accounts Receivables
| 0 | 0 | 0 | 0 | 0 | -0.208 | 0.589 | -0.195 | 0.527 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0.065 | -0.061 | 0.679 | -0.841 | 0 |
| Accounts Payables
| 2.038 | -0.763 | 7.278 | 1.417 | 0.607 | 0.892 | 0.39 | -1.517 | -1.827 | 0 |
| Other Working Capital
| 14.075 | 28.827 | 8.263 | 16.29 | -0.264 | -20.812 | -4.75 | -21.754 | 2.141 | 0 |
| Other Non Cash Items
| 1.429 | -13.423 | 0.694 | 2.445 | 2.396 | 22.08 | 6.005 | 22.221 | 0.13 | 0 |
| Operating Cash Flow
| -342.301 | -293.187 | -178.546 | -117.802 | -70.72 | -23.217 | -22.563 | -27.855 | -25.312 | -293.187 |
| Investing Activities: | ||||||||||
| Investments In Property Plant And Equipment
| -3.808 | -3.954 | -10.503 | -18.892 | -1.099 | -0.387 | -1.014 | -0.892 | -1.265 | 0 |
| Acquisitions Net
| -0.078 | 0.385 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| -865.27 | -887.737 | -425.158 | 0 | 0 | -0.72 | -33.085 | -15.944 | -39.278 | 0 |
| Sales Maturities Of Investments
| 942.8 | 502.857 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| 0.078 | -0.385 | -0.425 | 0 | 0 | 25.176 | 30.51 | 32.879 | 4 | -388.834 |
| Investing Cash Flow
| 73.722 | -388.834 | -435.661 | -18.892 | -1.099 | 24.069 | -3.589 | 16.043 | -36.543 | -388.834 |
| Financing Activities: | ||||||||||
| Debt Repayment
| -31.25 | -372.274 | -31.25 | 0 | 0 | -0.069 | -0.159 | -0.24 | -6.921 | 0 |
| Common Stock Issued
| 517.505 | 251.315 | 328.251 | 5.53 | 60.058 | 2.794 | 20.751 | 0.06 | 0.538 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -21.069 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 62.361 | -0.398 | 126.601 | 435.305 | 0.06 | 0 | 0 | 0 | 88.727 | 623.191 |
| Financing Cash Flow
| 548.616 | 623.191 | 423.602 | 440.835 | 60.058 | 2.725 | 20.592 | -0.18 | 61.275 | 623.191 |
| Other Information: | ||||||||||
| Effect Of Forex Changes On Cash
| 548.755 | 0 | 0 | 0 | 0 | 1.095 | 0.102 | -0.196 | -0.262 | 0 |
| Net Change In Cash
| 98.935 | -58.83 | -190.605 | 304.141 | -11.761 | 4.672 | -5.458 | -12.188 | -0.842 | -58.83 |
| Cash At End Of Period
| 990.965 | 138.388 | 197.218 | 387.823 | 83.682 | 8.095 | 3.423 | 8.881 | 21.069 | 138.388 |